DUX4 and sarcoma: Eventually, Kondo and colleagues established NCC-CDS2-C1 patient-derived cell lines using a surgically resected tumor tissue from another patient with CIC::DUX4 sarcoma (CDS) containing a similar CIC::DUX4 fusion transcript (Yoshimatsu et al., 2020).